{"id":"https://genegraph.clinicalgenome.org/r/9c3756c2-cd00-47ac-83e3-e02ea53ee934v1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between *MT-TK* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of April 17, 2023. The *MT-TK* gene encodes the mitochondrial tRNA for lysine, which is located from m.8295-8364 on the heavy strand of the mitochondrial DNA (mtDNA). Defects of this tRNA lead to impaired mitochondrial translation, which leads to decreased synthesis of mtDNA-encoded subunits of oxidative phosphorylation (OXPHOS) complexes I, III, IV, and V, resulting in impaired OXPHOS enzyme activities. \n\nWhile various names could be given to the constellation of features seen in those with *MT-TK*-related disorders, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *MT-TK* phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Of note, *MT-TK* was first curated by this GCEP for its association with Leigh syndrome spectrum (LSS) on May 17, 2021 (SOP v8), with a final classification of definitive. This current curation for the association with primary mitochondrial disease includes cases with LSS.\n\n*MT-TK* was first reported in relation to maternally-inherited primary mitochondrial disease in 1990 (PMID:2112427), in an individual with myoclonic epilepsy and ragged red fibers (MERRF). Subsequent publications have described a wide spectrum of phenotypes seen in those with *MT-TK* pathogenic variants including MERRF, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), Leigh syndrome spectrum, and mitochondrial neurogastrointestinal encephalopathy (MNGIE), as well as lipomas, myopathy, hypertrophic cardiomyopathy, hearing loss, diabetes, and episodic ataxia (PMIDs: 9380435, 19618438, 17410322, 25559684, 1361099, 10868777, 35821181, 36675808). \n\nEvidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included 7 unique missense variants, 4 of which have been reviewed by the Mitochondrial Disease Variant Curation Expert Panel (VCEP) and classified as pathogenic or likely pathogenic (m.8313G>A, m.8344A>G , m.8356T>C, m.8363G>A). The 3 other variants have not yet been reviewed by the VCEP but had single fiber studies supportive of pathogenicity. There is a substantial amount of functional evidence for these variants, including numerous cybrid analyses, single fiber studies, and respiratory chain studies showing clear evidence of OXPHOS defects (PMIDs: 19618438, 12737626, 17410322, 1848674, 7739567, 15554876). Heteroplasmy levels of *MT-TK* variants can vary across multiple tissues from the same individual (PMIDs: 35821181, 1361099). In summary, 8 probands from 8 publications were included in this curation, however, there are many more cases reported in the literature (PMIDs: 10868777, 17410322, 35821181, 1361099, 36675808, 25559684, 19618438, 9380435). \n\nThis gene-disease association is also supported by functional implication given protein interaction with the multitude of other mitochondrial translation proteins linked to primary mitochondrial disease and compelling single fiber data from patientsâ€™ cells (not included in case scoring) that were indicative of mitochondria dysfunction, and a mouse model of the m.8328G>A variant (PMIDs: 30030363, 10220860, 28729369, 24510903).\n\nIn summary, there is definitive evidence to support this gene-disease relationship, including that more than three years have elapsed since the first proposal of the association. No convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on April 17, 2023 (SOP Version 9). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/9c3756c2-cd00-47ac-83e3-e02ea53ee934","GCISnapshot":"https://genegraph.clinicalgenome.org/r/3d7a973c-7786-48a1-bf82-3764761739ba","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/3d7a973c-7786-48a1-bf82-3764761739ba_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2023-08-22T17:10:21.239Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/3d7a973c-7786-48a1-bf82-3764761739ba_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2023-04-17T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3d7a973c-7786-48a1-bf82-3764761739ba_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50e1e4df-6a48-4148-9faf-d8bd01b5d3bb","type":"EvidenceLine","dc:description":"0.5 (VCEP LPath) + Cybrid study (recurrent pathogenic variant)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50e1e4df-6a48-4148-9faf-d8bd01b5d3bb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Recurrent pathogenic variant - 0.5 (VCEP LPath) + Cybrid study (PMID: 15554876):","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/50e1e4df-6a48-4148-9faf-d8bd01b5d3bb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35821181","allele":{"id":"https://genegraph.clinicalgenome.org/r/d360a97b-97c0-4d56-b6fd-dbcfe86a44d7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_012920.1:m.8363G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA120555"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2a62d1dd-a597-4e51-b773-3cac110581e5","type":"EvidenceLine","dc:description":"0.5 (VCEP LPath) + 1 cybrid study (PMID: 12737626), also single fiber study on another patient (PMID: 19618438)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a62d1dd-a597-4e51-b773-3cac110581e5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.5 (VCEP LPath) + 0.4 Combined OXPHOS deficiency in muscle + 1 cybrid study (PMID: 12737626), also single fiber study on another patient (PMID: 19618438)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2a62d1dd-a597-4e51-b773-3cac110581e5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9380435","allele":{"id":"https://genegraph.clinicalgenome.org/r/12676cf8-39d9-4956-8baf-7fbd747b8251","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_012920.1:m.8313G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA254837"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/553b8627-6a7a-4713-af32-8aed203fd84d","type":"EvidenceLine","dc:description":"0.5 (Confirmed Path VCEP) + 1 Cybrid data (PMID: 7739567)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/553b8627-6a7a-4713-af32-8aed203fd84d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.5 (Confirmed Path VCEP) + 1 Cybrid data (PMID: 7739567)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/553b8627-6a7a-4713-af32-8aed203fd84d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36675808","allele":{"id":"https://genegraph.clinicalgenome.org/r/aea4acb4-f60d-474a-b750-5bdf7da717c8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_012920.1:m.8344A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA254836"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/16e8ca8d-dab8-4fcb-9c22-a72d10c1371b","type":"EvidenceLine","dc:description":"VCEP confirmed likely pathogenic (0.5) + 1 (cybrid PMID: 15554876)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16e8ca8d-dab8-4fcb-9c22-a72d10c1371b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"VCEP confirmed pathogenic (0.5) + 1 (cybrid)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/16e8ca8d-dab8-4fcb-9c22-a72d10c1371b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10868777","allele":{"id":"https://genegraph.clinicalgenome.org/r/d360a97b-97c0-4d56-b6fd-dbcfe86a44d7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c970105b-22e8-4dce-b151-1a85568642ce","type":"EvidenceLine","dc:description":"0.5 VCEP (LPath) + 1 for single fiber study","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c970105b-22e8-4dce-b151-1a85568642ce_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.5 VCEP (LPath) + 1 for single fiber study","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c970105b-22e8-4dce-b151-1a85568642ce_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19618438","allele":{"id":"https://genegraph.clinicalgenome.org/r/12676cf8-39d9-4956-8baf-7fbd747b8251"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d2f53bc6-2bbd-41c2-8cb2-24ad63f321cc","type":"EvidenceLine","dc:description":"0.5 (VCEP Lpath) + 1 cybrid study ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d2f53bc6-2bbd-41c2-8cb2-24ad63f321cc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.5 (VCEP Lpath) + 1 cybrid study ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d2f53bc6-2bbd-41c2-8cb2-24ad63f321cc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1361099","allele":{"id":"https://genegraph.clinicalgenome.org/r/fcfd08c8-783a-4913-9c78-c2580ea6e899","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_012920.1:m.8356T>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA120554"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/9c141eca-0cfb-45e2-be7e-95fe522af364","type":"EvidenceLine","dc:description":"VCEP Path + 1 cybrid study (PMIDs: 7739567)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c141eca-0cfb-45e2-be7e-95fe522af364_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"VCEP Path + 1 cybrid study","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9c141eca-0cfb-45e2-be7e-95fe522af364_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25559684","allele":{"id":"https://genegraph.clinicalgenome.org/r/aea4acb4-f60d-474a-b750-5bdf7da717c8"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/edc0c2f6-3a38-4abe-ba06-1894b39434c7","type":"EvidenceLine","dc:description":"0.1 (rare, segregation across tissues) + 0.25 (in silico agree pathogenic) + 0.4 (reduced aminoacylation activity)+ 1 SFS","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/edc0c2f6-3a38-4abe-ba06-1894b39434c7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.1 (rare, segregation across tissues) + 0.25 (in silico agree pathogenic)  + 0.4 (PMID: 15477393 - 5000 fold aminoacylation activity loss) + 1 SFS","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/edc0c2f6-3a38-4abe-ba06-1894b39434c7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17410322","allele":{"id":"https://genegraph.clinicalgenome.org/r/443cf698-e440-42fa-8cc1-c44379519749","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_012920.1:m.8328G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913178984"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/3d7a973c-7786-48a1-bf82-3764761739ba_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3d7a973c-7786-48a1-bf82-3764761739ba_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8bfb95e1-19b9-455f-a18e-5cf5e1ca9b79","type":"EvidenceLine","dc:description":"0.5 (selection against high levels of heteroplasmy >85%) + 0.5 (phenotype) + 0.5 (respiratory chain deficiency in muscle) + 05 (respiratory chain deficiency in kidney)","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31d0808b-dd21-4a04-b8d4-d054fa34d22a","type":"Finding","dc:description":"-Our failure to obtain mito-mice-tRNALys7731 with more than 85% G7731A mtDNA can be explained by the lethality of mouse oocytes carrying these levels of G7731A mtDNA (Fig. 3B)\n\n-(76-84%) high levels of G7731A mtDNA showed short body length (Fig. 4A) and muscle weakness by grip strength (Fig. 4B) - (0.5 for phenotype)\n\n-We then quantitatively estimated mitochondrial respiratory function and revealed respiration defects in skeletal muscle and kidney from mito-mice-tRNALys7731 (0.5 + 0.5 - per tissue) ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24510903","rdfs:label":"Mouse model of 8328G>A Variant","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3d7a973c-7786-48a1-bf82-3764761739ba_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/342f624d-c7ca-42ea-bde0-f17a5fb5873e","type":"EvidenceLine","dc:description":"Cybrid studies used as justification for variant pathogenicity in case scoring - not scored separately ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c9507d2-10b9-4961-bc4d-22e7f2554a29","type":"FunctionalAlteration","dc:description":"in the cybrid cell lines harboring only the m.8363G>A variant, the following was seen:\n-OCR: 0 (equal to 143B/206 (rho) cell line)\n-Complex I,III, IV reduced by ETC with normal CS and normal complex II\n\n-The tRNALys harbouring the G8363A mutation had a drastic reduction in the amount of its aminoacylated form (18% of control),\n\n-we performed non-denaturing single-strand analysis as described in the Materials and methods section. In contrast with the lack of effect observed in tRNA stability, the G8363A mutation produces a drastic shift in the mobility of the tRNALys, and practically the entire tRNA shows a delayed migration\n\n-Marked decreased in mitochondrial translation by S35 labeling","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15554876","rdfs:label":"Cybrid studies of m.8363G>A"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/9c3817b9-70b0-4440-b970-7cb23ad2350c","type":"EvidenceLine","dc:description":"Evidence from cybrids from this publication will be used to support case scoring","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/467a161d-2db4-4ec7-9f44-df35f249652d","type":"FunctionalAlteration","dc:description":"For each mutation, cytoplasmic hybrid (cybrid) cell lines containing 0 or 100% mutated mtDNAs (8344A>G or 8356T>C) were isolated and their genetic, biochemical, and morphological characteristics were examined. Both mutations resulted in the same biochemical and molecular genetic phenotypes. 4 cell lines of each type\n\nThere were no significant differences in the levels of mtDNA present in cybrids containing mutated mtDNAs compared with the levels in cybrid or control cell lines (data not shown).\n\nOCR: The rates of oxygen consumption were decreased approximately 10-fold in cybrids harboring 100% of either the MERRF-8344 or the MERRF-8356 point mutation compared to WT\n\nWild-type cybrids had a rate of oxygen consumption that was similar to that of the 143B\ncell line (4.01 6 0.30 fmol per cell per min [32]).\n\nBoth cybrid lines showed normal SDH staining but marked decreased in COX staining with the 143B showing no COX staining as epxected\n\nS35  methionine and S35 cysteine labeled protein tranlsation study\nFor MERRF-8344 cybrids, the values (expressed as a percentage of the level of\nlabeling observed in wild-type cybrids) ranged from 24% for ND2 to 63% for ND3; \nfor MERRF-8356 cybrids, the values ranged from 25% for ND2 to 100% for ND4 (Fig. 2C).\n\n8356 cybrids show WT level steady state MT-TK (relative MT-TL1), 8344 show reduced ratio of steady state MT-TK (~60% of control) ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7739567","rdfs:label":"Cybrid analysis of m.8344A>G and m.8356T>C"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/4e283711-4a94-4bac-9544-640d0a7b1129","type":"EvidenceLine","dc:description":"0.5 for ETC + 0.5 for single fiber study","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/597468d6-dad7-4e44-8a47-642293103651","type":"FunctionalAlteration","dc:description":"ETC (muscle):\nElevated CS, very low I, III, IV, V (all <30%)\nComplex II = ~50%\n\nSingle muscle fiber analysis:\n-74% (n=26, SD=15.0) in COX-negative fibers \n-53% mutant mtDNA in COX-positive fibers (n=28, SD=24.0) (P<0.0003).\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10220860","rdfs:label":"m.8342G>A Patient studies"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2e9ae2dd-b003-4235-8961-875b462058aa","type":"EvidenceLine","dc:description":"Score 1 point for single fiber study","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0460e966-a306-4fee-bc65-35f994fda922","type":"FunctionalAlteration","dc:description":"39-year-old male patient with sensorineural deafness who presented to the eye clinic with nyctalopia, retinal pigmentary changes and bilateral cortical cataracts NO PEO\n\nAt 5 years of age he was diagnosed and treated for myoclonic epilepsy. He stopped treatment at the age of 15 years and has remained seizure free since.\n\n\nMuscle biopsy analysis showed remarkable mitochondrial histochemical abnormalities characterised by a mosaic pattern of cytochrome c oxidase (COX) deficiency affecting ~40% of all fibres on both the individual enzyme reaction and the sequential cytochrome c oxidase-succinate dehydrogenase (COX-SDH) reaction (figure 3A) and subsarcolemmal mitochondrial accumulation (ragged-blue fibres affecting ~5% of the total biopsy) on the individual SDH reaction\n\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28729369","rdfs:label":"Single Fiber Studies in Patient Muscle Tissue "}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3d7a973c-7786-48a1-bf82-3764761739ba_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a4f3f43-0d33-421d-973b-d6374ff60fba","type":"EvidenceLine","dc:description":"13 OXPHOS polypeptides in mtDNA which is >10 genes\n","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea1f1de0-9dbf-4dcd-be18-69c907f9b95e","type":"Finding","dc:description":">10 genes involved in mitochondrial translation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30030363","rdfs:label":"Overview of mitochondrial transcription and translation","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":6735,"specifiedBy":"GeneValidityCriteria9","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/JJncQuJkzAk","type":"GeneValidityProposition","disease":"obo:MONDO_0044970","gene":"hgnc:7489","modeOfInheritance":"obo:HP_0001427"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_3d7a973c-7786-48a1-bf82-3764761739ba-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}